• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌患者肺切除术后胸腔灌洗细胞学检查及 20ml 生理盐水的可行性。

Pleural lavage cytology after lung resection in patients with non-small cell lung cancer and the feasibility of 20 mL saline solution.

机构信息

Department of General Thoracic Surgery, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Hamamatsu, Shizuoka, Japan.

Department of Pathology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Hamamatsu, Shizuoka, Japan.

出版信息

Asian J Surg. 2019 Jan;42(1):283-289. doi: 10.1016/j.asjsur.2018.03.001. Epub 2018 Apr 5.

DOI:10.1016/j.asjsur.2018.03.001
PMID:29628439
Abstract

BACKGROUND

There are two issues to be discussed in pleural lavage cytology (PLC) for resected non-small cell lung cancer (NSCLC) whether it should be performed before (pre-PLC) or after (post-PLC) the lung resection and the dose of saline varies widely among the institutions.

METHODS

We retrospectively reviewed the clinical records of 466 consecutive patients who underwent a curative resection for NSCLC and received both a pre- and post- PLC using 20 mL of saline from January 2001 to December 2011.

RESULTS

There were 24/28 of positive pre- and post-PLC and 442/438 negative pre- and post-PLCs, respectively. Patients with a positive pre- or post-PLCs had significantly worse 5-year survival rates than those with negative results (pre-PLC positive/negative; 32.6%/69.9%, p = 0.001, post-PLC positive/negative; 21.4%/71.1%, p < 0.001, respectively). The post-PLC (p = 0.01) was an independent prognostic factor for the overall survival by a multivariate analysis, whereas the pre-PLC was not (p = 0.79).

CONCLUSIONS

The post-PLC was a more significant prognostic factor than the pre-PLC. Further, 20 mL of saline seemed feasible because of the consistent results compared to the past reports using a greater dose of saline for regarding the positive rates of the PLC and its prognostic significance.

摘要

背景

在切除的非小细胞肺癌(NSCLC)的胸膜灌洗细胞学(PLC)中,有两个问题需要讨论,即它应该在肺切除之前(PLC 前)还是之后(PLC 后)进行,以及各机构之间生理盐水的剂量差异很大。

方法

我们回顾性分析了 2001 年 1 月至 2011 年 12 月期间,466 例接受 NSCLC 根治性切除并接受 20ml 生理盐水 PLC 前和 PLC 后治疗的连续患者的临床记录。

结果

PLC 前和 PLC 后分别有 24/28 例阳性和 442/438 例阴性。PLC 前或 PLC 后阳性的患者 5 年生存率明显低于阴性结果的患者(PLC 前阳性/阴性;32.6%/69.9%,p=0.001,PLC 后阳性/阴性;21.4%/71.1%,p<0.001)。多因素分析显示,PLC 后(p=0.01)是总生存的独立预后因素,而 PLC 前不是(p=0.79)。

结论

与过去使用更大剂量生理盐水的报告相比,PLC 后是比 PLC 前更显著的预后因素。进一步地,20ml 的生理盐水似乎是可行的,因为与阳性率及其预后意义有关的 PLC 结果一致。

相似文献

1
Pleural lavage cytology after lung resection in patients with non-small cell lung cancer and the feasibility of 20 mL saline solution.非小细胞肺癌患者肺切除术后胸腔灌洗细胞学检查及 20ml 生理盐水的可行性。
Asian J Surg. 2019 Jan;42(1):283-289. doi: 10.1016/j.asjsur.2018.03.001. Epub 2018 Apr 5.
2
Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology.胸腔灌洗细胞学检查阳性的非小细胞肺癌患者的预后
Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):777-82. doi: 10.1093/icvts/ivv047. Epub 2015 Mar 11.
3
Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.非小细胞肺癌患者肺切除术前和术后的胸腔灌洗细胞学检查
Ann Thorac Surg. 2006 Jan;81(1):298-304. doi: 10.1016/j.athoracsur.2005.06.073.
4
The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer.肺切除术前和术后胸腔灌洗细胞学检查对非小细胞肺癌复发的影响
Ann Thorac Surg. 2016 Jun;101(6):2141-6. doi: 10.1016/j.athoracsur.2015.12.037. Epub 2016 Mar 22.
5
Prognostic value of intraoperative pleural lavage cytology for non-small cell lung cancer: the influence of positive pleural lavage cytology results on T classification.术中胸膜腔灌洗细胞学检查对非小细胞肺癌的预后价值:阳性胸膜腔灌洗细胞学结果对T分期的影响
J Thorac Cardiovasc Surg. 2014 Dec;148(6):2659-64. doi: 10.1016/j.jtcvs.2014.07.090. Epub 2014 Aug 6.
6
Pleural lavage cytology predicts recurrence and survival, even in early non-small cell lung cancer.即使在早期非小细胞肺癌中,胸腔灌洗细胞学检查也能预测复发和生存情况。
Surg Today. 2015 Mar;45(3):322-8. doi: 10.1007/s00595-014-0915-3. Epub 2014 May 10.
7
Efficacy of adjuvant chemotherapy for lung adenocarcinoma patients with positive pleural lavage cytology findings.辅助化疗对胸腔灌洗细胞学检查结果阳性的肺腺癌患者的疗效。
Interact Cardiovasc Thorac Surg. 2015 Jul;21(1):34-9. doi: 10.1093/icvts/ivv098. Epub 2015 Apr 23.
8
Clinicopathological features of intraoperative pleural lavage cytology for non-small cell lung cancer.非小细胞肺癌术中胸腔冲洗细胞学检查的临床病理特征
Gen Thorac Cardiovasc Surg. 2020 Feb;68(2):164-169. doi: 10.1007/s11748-019-01170-y. Epub 2019 Jul 9.
9
Positive intraoperative pleural lavage cytology is a predictive marker of disease recurrence in stage I lung adenocarcinoma.术中胸腔灌洗细胞学检查结果为阳性是Ⅰ期肺腺癌疾病复发的一个预测指标。
Interact Cardiovasc Thorac Surg. 2014 May;18(5):621-5. doi: 10.1093/icvts/ivu015. Epub 2014 Feb 13.
10
Pleural lavage cytology in non-small cell lung cancer: lessons from 1000 consecutive resections.非小细胞肺癌的胸腔灌洗细胞学检查:来自1000例连续切除术的经验教训。
J Thorac Cardiovasc Surg. 2003 Dec;126(6):1911-5. doi: 10.1016/s0022-5223(03)00715-3.

引用本文的文献

1
Uncertain Resection in Lung Cancer: A Comprehensive Review of the International Association for the Study of Lung Cancer Classification.肺癌的不确定切除:国际肺癌研究协会分类的综合综述
Cancers (Basel). 2025 Apr 22;17(9):1386. doi: 10.3390/cancers17091386.
2
The importance of endobag use with incision-protective devices in VATS lung resection: a preliminary study.经皮穿刺器联合切口保护器在 VATS 肺切除术中应用的重要性:一项初步研究。
BMC Res Notes. 2022 May 10;15(1):158. doi: 10.1186/s13104-022-06047-7.
3
Comparison of the clinical benefits for non-small cell lung cancer patients between different volume of pleural lavage fluid following video-assisted thoracoscopic lobectomy and systematic mediastinal lymph node dissection: study protocol for a randomized controlled trial.
不同容量胸腔灌洗对行电视辅助胸腔镜肺叶切除并系统性纵隔淋巴结清扫术的非小细胞肺癌患者临床获益的比较:一项随机对照试验的研究方案。
Trials. 2020 Feb 27;21(1):232. doi: 10.1186/s13063-020-4146-1.